Skip to content
2000
Volume 25, Issue 13
  • ISSN: 1871-5303
  • E-ISSN: 2212-3873
file format text download EPUB
file format pdf download PDF
side by side viewer icon HTML

Abstract

Background

Hepatic inflammation, , Nonalcoholic Fatty Liver Diseases (NAFLD) and the severe form of steatohepatitis (NASH), has been associated with a higher risk of MetS in the general population.

Aims

This study aimed to investigate the associations of chronic hepatitis B (CHB) and fatty liver diseases with the incidence of metabolic syndrome (MetS) in young adults, which have not been verified before.

Objective

The associations between NAFLD, NASH, and CHB and the incidence of new-onset MetS remain inconclusive in young adults.

Methods

This cohort study included 2,614 military personnel aged 18-39 years who were free of baseline MetS in 2014 and were followed for the incidence of MetS in each annual health examination until the end of 2020. CHB was defined by the presence of the hepatitis B surface antigen with an established diagnosis history. NAFLD and NASH were defined by the ultrasound finding with an elevated alanine transaminase (27-53.9 and ≥54 U/L in men and 15-29.9 and ≥30 U/L in women, respectively). MetS was defined based on the International Diabetes Federation criteria. Multivariable Cox regression analysis was used to determine the associations between hepatitis and incident MetS.

Results

During a mean follow-up of 6.0 years, 582 new-onset MetS cases occurred (22.3%). NAFLD and NASH were associated with a greater risk of new-onset MetS (hazard ratios (HRs) and 95% confidence intervals: 1.47 (1.21-1.79) and 1.66 (1.16-2.39), respectively), while no association for CHB was found (HR: 1.31 (0.88-1.96)).

Conclusion

This study found that NAFLD and NASH, while not CHB, were independent risk factors of new-onset MetS with adjustments for potential covariates, , physical activity and fitness in young adults.

© 2025 The Author(s). Published by Bentham Science Publishers.
This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/emiddt/10.2174/0118715303323078241022050619
2025-01-09
2026-01-01

  • From This Site

    /content/journals/emiddt/10.2174/0118715303323078241022050619
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/emiddt/25/13/EMIDDT-25-13-05.html?itemId=/content/journals/emiddt/10.2174/0118715303323078241022050619&mimeType=html&fmt=ahah

References

  1. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report.Circulation2002106253143342110.1161/circ.106.25.314312485966
     [Google Scholar]
  2. TsaiK.Z. HuangW.C. SuiX. LavieC.J. LinG.M. Moderate or greater daily coffee consumption is associated with lower incidence of metabolic syndrome in Taiwanese militaries: Results from the CHIEF cohort study.Front. Nutr.202310132191610.3389/fnut.2023.132191638156279
     [Google Scholar]
  3. RanasingheP. MathangasingheY. JayawardenaR. HillsA.P. MisraA. Prevalence and trends of metabolic syndrome among adults in the asia-pacific region: A systematic review.BMC Public Health201717110110.1186/s12889‑017‑4041‑128109251
     [Google Scholar]
  4. SaklayenM.G. The global epidemic of the metabolic syndrome.Curr. Hypertens. Rep.20182021210.1007/s11906‑018‑0812‑z29480368
     [Google Scholar]
  5. TylutkaA. MorawinB. WalasŁ. MichałekM. GwaraA. Zembron-LacnyA. Assessment of metabolic syndrome predictors in relation to inflammation and visceral fat tissue in older adults.Sci. Rep.20231318910.1038/s41598‑022‑27269‑636596839
     [Google Scholar]
  6. WangC.C. ChengP.N. KaoJ.H. Systematic review: Chronic viral hepatitis and metabolic derangement.Aliment. Pharmacol. Ther.202051221623010.1111/apt.1557531746482
     [Google Scholar]
  7. SiegelA.B. ZhuA.X. Metabolic syndrome and hepatocellular carcinoma.Cancer2009115245651566110.1002/cncr.2468719834957
     [Google Scholar]
  8. WongV.W.S. WongG.L.H. ChuW.C.W. ChimA.M.L. OngA. YeungD.K.W. YiuK.K.L. ChuS.H.T. ChanH.Y. WooJ. ChanF.K.L. ChanH.L.Y. Hepatitis B virus infection and fatty liver in the general population.J. Hepatol.201256353354010.1016/j.jhep.2011.09.01322027575
     [Google Scholar]
  9. KatoonizadehA. GhoroghiS. SharafkhahM. KhoshniaM. MirzaeiS. ShayanradA. PoustchiH. MalekzadehR. Chronic hepatitis B infection is not associated with increased risk of vascular mortality while having an association with metabolic syndrome.J. Med. Virol.20168871230123710.1002/jmv.2446626742819
     [Google Scholar]
  10. WangC.C. TsengT.C. KaoJ.H. Hepatitis B virus infection and metabolic syndrome: Fact or fiction?J. Gastroenterol. Hepatol.2015301142010.1111/jgh.1270025092429
     [Google Scholar]
  11. LiW.C. LeeY.Y. ChenI.C. SunC. ChiuF.H. ChuangC.H. Association between the hepatitis B and C viruses and metabolic diseases in patients stratified by age.Liver Int.20133381194120210.1111/liv.1222423782533
     [Google Scholar]
  12. ChungT.H. KimM.C. KimC.S. Association between hepatitis B surface antigen seropositivity and metabolic syndrome.Korean J. Fam. Med.2014352818910.4082/kjfm.2014.35.2.8124724003
     [Google Scholar]
  13. JanC-F. ChenC-J. ChiuY-H. ChenL-S. WuH-M. HuangC-C. YenM-F. ChenT.H-H. A population-based study investigating the association between metabolic syndrome and Hepatitis B/C infection (Keelung Community-based Integrated Screening Study No. 10).Int. J. Obes.200630579479910.1038/sj.ijo.080320416404404
     [Google Scholar]
  14. LinG.M. LiY.H. LeeC.J. ShiangJ.C. LinK.H. ChenK.W. ChenY.J. WuC.F. LinB.S. YuY.S. LinF. SuF.Y. WangC.H. Rationale and design of the cardiorespiratory fitness and hospitalization events in armed forces study in Eastern Taiwan.World J. Cardiol.20168846447110.4330/wjc.v8.i8.46427621774
     [Google Scholar]
  15. LinJ.W. TsaiK.Z. ChenK.W. SuF.Y. LiY.H. LinY.P. HanC.L. LinF. LinY.K. HsiehC.B. LinG.M. Sex-Specific association between serum uric acid and elevated alanine aminotransferase in a military cohort: The chief study.Endocr. Metab. Immune Disord. Drug Targets201919333334010.2174/187153031966618112916380230499423
     [Google Scholar]
  16. TsaiK.Z. LinJ-W. LinF. SuF-Y. LiY-H. LinY-P. LinY-K. HanC-L. HsiehC-B. LinG-M. Association of betel nut chewing with exercise performance in a military male cohort: The CHIEF study.J. R. Army Med. Corps2018164639940410.1136/jramc‑2017‑00089930012664
     [Google Scholar]
  17. WangS.H. ChungP.S. LinY.P. TsaiK.Z. LinS.C. FanC.H. LinY.K. LinG.M. Metabolically healthy obesity and physical fitness in military males in the CHIEF study.Sci. Rep.2021111908810.1038/s41598‑021‑88728‑033907258
     [Google Scholar]
  18. ChenY.J. ChenK.W. ShihY.L. SuF.Y. LinY.P. MengF.C. LinF. YuY.S. HanC.L. WangC.H. LinJ.W. HsiehT.Y. LiY.H. LinG.M. Chronic hepatitis B, nonalcoholic steatohepatitis and physical fitness of military males: CHIEF study.World J. Gastroenterol.201723254587459410.3748/wjg.v23.i25.458728740347
     [Google Scholar]
  19. SuhS.Y. ChoiS.E. AhnH.Y. YangH.M. KimY.I. SungN.J. The association between normal alanine aminotransferase levels and the metabolic syndrome: 2005 Korean National Health and Nutrition Examination Survey.Metabolism200958121731173610.1016/j.metabol.2009.05.02819604521
     [Google Scholar]
  20. World Health OrganizationObesity: Preventing and managing the global epidemic. Report of a WHO consultation.Geneva, SwitzerlandWorld Health Organization200011234459
     [Google Scholar]
  21. TsaiK.Z. HuangR.Y. ChengW.C. HanC.L. HuangW.C. SuiX. LavieC.J. LinG.M. Association between dental calculus and hypertension phenotypes in highly fit adults: CHIEF oral health study.Am. J. Hypertens.202336210210810.1093/ajh/hpac11936270011
     [Google Scholar]
  22. LinG-M. ChouY-T. ChenK-W. LiuP-Y. TsaiK-Z. LinY.P. Hepatic and systemic inflammation for left ventricular mass in physically fit adults: Chief heart study.Endocr. Metab. Immune Disord. Drug Targets202323797798310.2174/187153032366623011914501036658706
     [Google Scholar]
  23. LinG.M. LiuP.Y. TsaiK.Z. LinY.K. HuangW.C. LavieC. Cardiorespiratory fitness and carotid intima–media thickness in physically active young adults: Chief atherosclerosis study.J. Clin. Med.20221113365310.3390/jcm1113365335806938
     [Google Scholar]
  24. FarrellG.C. ChitturiS. LauG.K.K. SollanoJ.D. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: Executive summary.J. Gastroenterol. Hepatol.200722677577710.1111/j.1440‑1746.2007.05002.x17565629
     [Google Scholar]
  25. HabibullahM. JemmiehK. OudaA. HaiderM.Z. MalkiM.I. ElzoukiA.N. Metabolic-associated fatty liver disease: A selective review of pathogenesis, diagnostic approaches, and therapeutic strategies.Front. Med. (Lausanne)202411129150110.3389/fmed.2024.129150138323033
     [Google Scholar]
  26. PassosE. AscensãoA. MartinsM.J. MagalhãesJ. Endoplasmic reticulum stress response in non-alcoholic steatohepatitis: The possible role of physical exercise.Metabolism201564778079210.1016/j.metabol.2015.02.00325838034
     [Google Scholar]
  27. AshrafN.U. SheikhT.A. Endoplasmic reticulum stress and Oxidative stress in the pathogenesis of Non-alcoholic fatty liver disease.Free Radic. Res.201549121405141810.3109/10715762.2015.107846126223319
     [Google Scholar]
  28. AngelicoF. Alcantara-PayawalD. RaniR.A. MustafaN. ThongtangN. ChaiteerakijR. Review and expert opinion on MAFLD, oxidative stress and multifunctional management.Drugs Context202320241338264403
     [Google Scholar]
  29. PolyzosS.A. ToulisK.A. GoulisD.G. ZavosC. KountourasJ. Serum total adiponectin in nonalcoholic fatty liver disease: A systematic review and meta-analysis.Metabolism201160331332610.1016/j.metabol.2010.09.00321040935
     [Google Scholar]
  30. JinjuvadiaR. LiangpunsakulS. Association between metabolic syndrome and its individual components with viral hepatitis B.Am. J. Med. Sci.20143471232710.1097/MAJ.0b013e31828b25a523514672
     [Google Scholar]
  31. LiY. ZhaoY. WuJ. Serum HBV surface antigen positivity is associated with low prevalence of metabolic syndrome: A meta-analysis.PLoS One2017125e017771310.1371/journal.pone.017771328505202
     [Google Scholar]
  32. ZhouY. CuiY. DengH. YuJ. Association between hepatitis B virus infection and metabolic syndrome: A retrospective cohort study in Shanghai, China.BMC Public Health201414151610.1186/1471‑2458‑14‑51624885963
     [Google Scholar]
  33. MasakiT. ChibaS. TatsukawaH. YasudaT. NoguchiH. SeikeM. YoshimatsuH. Adiponectin protects LPS-induced liver injury through modulation of TNF-? in KK-Ay obese mice.Hepatology200440117718410.1002/hep.2028215239101
     [Google Scholar]
  34. RaziB. AlizadehS. OmidkhodaA. ImaniD. RezaeiR. Association of chronic hepatitis B infection with metabolic syndrome and its components: Meta-analysis of observational studies.Diabetes Metab. Syndr.201711Suppl. 2S939S94710.1016/j.dsx.2017.07.02028701286
     [Google Scholar]
  35. YenS-L. ChiuT-Y. LinY-C. LeeY-C. LeeL-T. HuangK-C. Obesity and hepatitis B infection are associated with increased risk of metabolic syndrome in university freshmen.Int. J. Obes.200832347448010.1038/sj.ijo.080375317955029
     [Google Scholar]
  36. CusiK. IsaacsS. BarbD. BasuR. CaprioS. GarveyW.T. KashyapS. MechanickJ.I. MouzakiM. NadolskyK. RinellaM.E. VosM.B. YounossiZ. American association of clinical endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings.Endocr. Pract.202228552856210.1016/j.eprac.2022.03.01035569886
     [Google Scholar]
/content/journals/emiddt/10.2174/0118715303323078241022050619
Loading
Associations of Chronic Hepatitis B and Nonalcoholic Fatty Liver Diseases with New-Onset Metabolic Syndrome in Military Personnel before Midlife: A Cohort Study
Endocr Metab Immune Disord Drug Targets 25, 1073 (2025); https://doi.org/10.2174/0118715303323078241022050619
/content/journals/emiddt/10.2174/0118715303323078241022050619
/content/journals/emiddt/10.2174/0118715303323078241022050619
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher's website along with the published article.

file format download Download

  • Article Type:     Research Article
Keyword(s): Chronic hepatitis B; metabolic syndrome; military health; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis; young adults

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test